Benefit of combination &beta;-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

479

HTML

2026

Figures (1-1)

219

Tables (1-6)

261

Sum=2985

Dec 21, 2010 (publication date) through Feb 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 21, 2010; 16(47): 5982-5992
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5982

Table 6 Subgroup meta-analysis including trials comparing banding ligation with banding ligation and β-blockers

	BL, n/N (%)	BL + BB, n/N (%)	No. of trials analysed	I²	OR (95% CI)	P for heterogeneity	P-value
Overall all-cause rebleeding	49/124 (39.5)	22/128 (17.2)	3	0	3.16 (1.76-5.34)¹	0.85	< 0.0001
Mortality	27/124 (21.8)	17/128 (13.3)	3	0	1.78 (0.92-3.43)¹	0.53	0.09

¹Fixed effect model. SCL: Sclerotherapy; BL: Banding ligation; BB: β-blockers; OR: Odds ratio; CI: Confidence interval.

Citation: Funakoshi N, Ségalas-Largey F, Duny Y, Oberti F, Valats JC, Bismuth M, Daurès JP, Blanc P. Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis. World J Gastroenterol 2010; 16(47): 5982-5992
URL: https://www.wjgnet.com/1007-9327/full/v16/i47/5982.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i47.5982